MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.46−0.28 (-3.20%)
Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –
MeiraGTx price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
MeiraGTx's price to book ratio was 246.8× on Oct 31, 2025, against 4.5× a year earlier. Over the last 5 years it ranged from 2.1× to 246.8×, with a median of 3.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 246.8× | +241.8 |
| 2024 | Dec 31, 2024 | 4.9× | +0.4 |
| 2023 | Dec 29, 2023 | 4.6× | +2.2 |
| 2022 | Dec 30, 2022 | 2.4× | −3.2 |
| 2021 | Dec 31, 2021 | 5.6× | +2.4 |
| 2020 | Dec 31, 2020 | 3.2× | −0.5 |
| 2019 | Dec 31, 2019 | 3.8× | +1.0 |
| 2018 | Dec 31, 2018 | 2.7× | – |
See a number that looks wrong?